Theravance Biopharma Inc (TBPH)
Equity Ratio
61.67%
Quarterly · Period ending:
TBPH Equity Ratio
Latest reported61.67%period ending
Latest reported61.67%period ending
TBPH Quarterly Equity Ratio (-33.35% → 61.67%)
Latest values, visible window
High-resolution chart · PNG
TBPH equity ratio history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Equity Ratio |
|---|---|
| 61.6695% | |
| 61.5257% | |
| 61.1082% | |
| 56.0056% | |
| 52.7769% | |
| 48.3096% | |
| 49.5664% | |
| 52.1346% | |
| 53.501% | |
| 55.1748% | |
| 55.758% | |
| 59.5106% | |
| 62.7278% | |
| 68.8068% | |
| 72.7363% | |
| 62.9444% | |
| -96.9642% | |
| -98.9% | |
| -90.3297% | |
| -80.2741% | |
| -69.9763% | |
| -99.4961% | |
| -64.7578% | |
| -51.0625% | |
| -35.8542% | |
| -26.0875% | |
| -54.7519% | |
| -41.0487% | |
| -27.8657% | |
| -21.3174% | |
| -9.2085% | |
| -3.6243% | |
| 8.1609% | |
| 13.2068% | |
| 26.0938% | |
| 37.8718% | |
| 44.3341% | |
| 49.9875% | |
| 54.7875% | |
| 83.6043% | |
| 85.873% | |
| 81.3772% | |
| 80.9904% | |
| 86.4232% | |
| 89.013% | |
| 88.9856% | |
| 85.7939% | |
| 89.0271% | |
| 89.3566% | |
| -68.4679% | |
| -67.661% | |
| -60.8668% | |
| -54.0482% | |
| -18.5933% | |
| -33.3461% |